Condor Capital Management Sells 75 Shares of Vertex Pharmace

Condor Capital Management lowered its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 1.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,023 shares of the pharmaceutical company’s stock after selling 75 shares during the period. Condor Capital Management’s holdings in Vertex Pharmaceuticals […]

Related Keywords

William Blair , Piper Sandler , Reshma Kewalramani , Brucei Sachs , Investment Management , Morgan Stanley , Cantor Fitzgerald , Telos Capital Management Inc , Vertex Pharmaceuticals Profile , News Ratings For Vertex Pharmaceuticals Daily , Barclays , Vertex Pharmaceuticals , Vertex Pharmaceuticals Trading , Quarter For Vertex Pharmaceuticals , Vertex Pharmaceuticals Incorporated , Sherbrooke Park Advisers , Canaccord Genuity Group , Condor Capital Management , Free Report , Capital Management , Park Advisers , Grey Street Capital , Street Capital , Director Bruce , Genuity Group , Pharmaceuticals Incorporated , Get Free Report , Visit Holdingschannel , Vertex Pharmaceuticals Daily ,